Today is World Alzheimer's Day 4:28 Epidemiologist Dr. Christian Salazar of UC Irvine discusses how Alzheimer’s disproportionately affects the Latino community on Yahoo News and CBSLA. Click to watch the inteerview
Read More
Controversial Alzheimer’s Drug Approval Sparks Surprising Impact “Alzheimer’s is the most important medical condition society faces and we need an army of citizen volunteers to participate in drug trials,” said UCI MIND’s Joshua Grill, with study leader Marina Ritchie. Click to read the article
Read More
Alzheimer’s drug that slows cognitive decline gets FDA approval UCI MIND Director, Dr, Joshua Grill is quoted in the Washington Post about the meaningfulness of lecanemab's clinical benefit. Further discussion on this topic is accessible on UCI MIND blog post. Click to read the article Click to read the blog post
Read More
Meet Orange County’s 125 most influential people for 2023 Dr. Joshua Grill, Director of UCI MIND is named one of Orange County’s 125 most influential people for 2023 by the Orange County Register! Click to read the article
Read More
Why the new Alzheimer’s drug is eliciting both optimism and caution UCI MIND Director, Dr. Joshua Grill is quoted in a National Geographic article about lecanemab Click to read the article
Read More
Want to make an IMPACT in Alzheimer’s clinical trials? Apply for IMPACT-AD A training course, directed by UCI MIND Director, Dr. Joshua Grill and Director of Biostatistics at USC Alzheimer's Therapeutic Research Institute. Click to learn more about IMPACT-AD
Read More
OC 50 2023 – 50 Shaping the Future of Healthcare in OC UCI MIND Director, Dr. Joshua Grill, is named one of this year’s OC50 (50 people shaping the future of healthcare in Orange County) in the Orange County Business Journal. Click to read the article
Read More
Alzheimer’s drug trials plagued by lack of racial diversity UCI MIND Director, Dr. Joshua Grill is quoted in Nature about the importance of diverse populations in drug trials. Click to read the article
Read More
UC Irvine is part of $16 million effort to increase dementia research representation UCI MIND Director, Dr. Joshua Grill is one of the three principal investigators for the National Institute on Aging grant that will fund CARE 2.0. Click to read the article Click to learn more about CARE 2.0
Read More
Consumers Can Now Buy a Blood Test to Evaluate Their Alzheimer Disease Risk, but Should They? Chief of the Memory Disorders Division at UCI, Dr. S. Ahmad Sajjadi, who co-authored a blog post with UCI MIND Director, Dr. Joshua Grill was interviewed by the JAMA Network to discuss further about AD-Detect Click to read the article Click to read the blog post
Read More